Verinomics, a pioneer in agricultural genomics and gene editing, has announced the launch of two groundbreaking platforms designed to fast-track specialty crop innovation. The Genesis™ platform delivers transgene-free gene editing, optimized for vegetatively propagated crops, while Genova™ accelerates genomic-driven breeding for both seed and vegetatively propagated crops. Together, these technologies are set to redefine trait discovery and product development, delivering market-ready crops faster than ever.
“By combining AI-powered genomic analysis with our transgene-free editing capabilities, we’re enabling the rapid development of improved crop varieties that would take decades through conventional breeding methods,” said Gio Scalzo, Chief Operating Officer at Verinomics.
Backed by $13 million in funding, Verinomics has developed a robust genomics-driven breeding and transgene-free editing pipeline. The company operates on a partner-first model, collaborating with nurseries, seed companies, and growers to co-develop high-value products with shared intellectual property.
Verinomics’ precision breeding approach integrates chromosome-level genome assemblies, population genomics, AI-based trait identification, and transgene-free gene editing to uncover the genetic basis of key traits and develop improved crop varieties without introducing foreign DNA.
The Genesis™ platform enables precise gene editing across a wide range of crops, particularly overcoming the breeding challenges of vegetatively propagated plants. Meanwhile, Genova™ leverages AI and computational biology to optimize genomic selection and trait identification, significantly shortening breeding cycles.
“Our vision is to harness genomic technologies to solve urgent challenges in agriculture,” said Dr. Stephen Dellaporta, President and Founder of Verinomics and a professor at Yale University. “Our technology allows us to rapidly identify valuable genetic traits and develop enhanced varieties without relying on traditional transgenic approaches.”
By working directly with industry stakeholders, Verinomics ensures its innovations are tailored to real-world agricultural needs. Their approach focuses on developing solutions that create clear market value across the supply chain.
Verinomics is already delivering results through strategic partnerships, including a multi-year collaboration with Burchell Nursery, a top almond nursery in the U.S.
“Our partnership with Verinomics has yielded breakthrough solutions for longstanding challenges in almond production,” said Tom Burchell, owner of Burchell Nursery. “Their gene editing approach to self-compatibility is transforming our almond growing operations—boosting yields while reducing resource requirements. What sets Verinomics apart is their deep understanding of grower needs before applying technology.”
Burchell Nursery is currently taking first-come, first-serve orders for the Nonpareil+ almond variety, expected in 2027.
Looking ahead, Verinomics is preparing for growth financing to scale its Genesis™ and Genova™ platforms into new high-value crop sectors. The company aims to drive broader adoption of next-generation, non-GMO breeding solutions to enhance crop resilience, nutrition, and sustainability.
“The company differentiates itself by starting with producer and consumer needs, then developing tailored solutions,” said Randall Lewis, Managing Partner at Cleveland Avenue and Verinomics board member. “Their proven technology platforms, world-class team, and commercial traction make them a compelling investment as they prepare to raise growth capital.”
With its AI-driven breeding acceleration and transgene-free gene editing, Verinomics is pushing the boundaries of agricultural innovation—bringing science-driven solutions to market faster than ever before.
Verinomics, a pioneer in agricultural genomics and gene editing, has announced the launch of two groundbreaking platforms designed to fast-track specialty crop innovation. The Genesis™ platform delivers transgene-free gene editing, optimized for vegetatively propagated crops, while Genova™ accelerates genomic-driven breeding for both seed and vegetatively propagated crops. Together, these technologies are set to redefine trait discovery and product development, delivering market-ready crops faster than ever.
“By combining AI-powered genomic analysis with our transgene-free editing capabilities, we’re enabling the rapid development of improved crop varieties that would take decades through conventional breeding methods,” said Gio Scalzo, Chief Operating Officer at Verinomics.
Backed by $13 million in funding, Verinomics has developed a robust genomics-driven breeding and transgene-free editing pipeline. The company operates on a partner-first model, collaborating with nurseries, seed companies, and growers to co-develop high-value products with shared intellectual property.
Verinomics’ precision breeding approach integrates chromosome-level genome assemblies, population genomics, AI-based trait identification, and transgene-free gene editing to uncover the genetic basis of key traits and develop improved crop varieties without introducing foreign DNA.
The Genesis™ platform enables precise gene editing across a wide range of crops, particularly overcoming the breeding challenges of vegetatively propagated plants. Meanwhile, Genova™ leverages AI and computational biology to optimize genomic selection and trait identification, significantly shortening breeding cycles.
“Our vision is to harness genomic technologies to solve urgent challenges in agriculture,” said Dr. Stephen Dellaporta, President and Founder of Verinomics and a professor at Yale University. “Our technology allows us to rapidly identify valuable genetic traits and develop enhanced varieties without relying on traditional transgenic approaches.”
By working directly with industry stakeholders, Verinomics ensures its innovations are tailored to real-world agricultural needs. Their approach focuses on developing solutions that create clear market value across the supply chain.
Verinomics is already delivering results through strategic partnerships, including a multi-year collaboration with Burchell Nursery, a top almond nursery in the U.S.
“Our partnership with Verinomics has yielded breakthrough solutions for longstanding challenges in almond production,” said Tom Burchell, owner of Burchell Nursery. “Their gene editing approach to self-compatibility is transforming our almond growing operations—boosting yields while reducing resource requirements. What sets Verinomics apart is their deep understanding of grower needs before applying technology.”
Burchell Nursery is currently taking first-come, first-serve orders for the Nonpareil+ almond variety, expected in 2027.
Looking ahead, Verinomics is preparing for growth financing to scale its Genesis™ and Genova™ platforms into new high-value crop sectors. The company aims to drive broader adoption of next-generation, non-GMO breeding solutions to enhance crop resilience, nutrition, and sustainability.
“The company differentiates itself by starting with producer and consumer needs, then developing tailored solutions,” said Randall Lewis, Managing Partner at Cleveland Avenue and Verinomics board member. “Their proven technology platforms, world-class team, and commercial traction make them a compelling investment as they prepare to raise growth capital.”
With its AI-driven breeding acceleration and transgene-free gene editing, Verinomics is pushing the boundaries of agricultural innovation—bringing science-driven solutions to market faster than ever before.